Neoplasia/BPH

	Integrating NLP to Enhance Algorithmic Identification of Metastatic and Castration-Resistant Prostate Cancer in Large Claims-Based Studies. Cancer Med Stock SR, Parrish JA, Burns MT, Janes JL, Waller J, De Hoedt AM, Ghate S, Kim J, Shui IM, Freedland SJ. PMID: 41423433 [PubMed - indexed for MEDLINE]
	Artificial intelligence-driven prostate cancer diagnosis: Enhancing accuracy and personalizing patient care. Urol Oncol Zhang X, Xiao N, Liang H, Li P, Zhang Y, Zhang S, Zhou B, Yao S, Yang Z, Chen J. PMID: 41423376 [PubMed - as supplied by publisher]
	Opportunistic screening for osteoporosis and vertebral fracture using CT attenuation from 18F-fluorocholine PET/CT in patients with prostate cancer. RMD Open Dauchez A, Dariane C, Fechtenbaum J, Bodard S, Guinebert S, Timsit MO, Roux C, Hyafil F, Briot K, Fogel O. PMID: 41423294 [PubMed - indexed for MEDLINE]
	Metastatic clear cell seminal vesicle carcinoma masquerading as high-grade prostate cancer. BMJ Case Rep M Khamis M, Walters ML, Rodgers HA. PMID: 41423288 [PubMed - indexed for MEDLINE]
	Association of Proteinuria as an Observed Side Effect with a Worsening Rate of Renal Function Decline in Patients with Colorectal Cancer Treated with Bevacizumab. Biol Pharm Bull Yamaguchi K, Fujimoto K, Sakurai M, Horie T, Takahashi Y, Ishigaki Y, Masauji T. PMID: 41423225 [PubMed - indexed for MEDLINE]
	Editorial comment on "Can novel biomarkers augment traditional surveillance paradigms in early-stage testicular germ cell tumors? A case study in pre-clinical relapse detection using a combination micro-RNA-371a-3p and 372-3p assay" (# URL-D-25-02183R1). Urology Dieckmann DK. PMID: 41423088 [PubMed - as supplied by publisher]
	A Daily Clinical Practice Decision-Making Overview for the Present metastatic Renal Cell Carcinoma (mRCC) management landscape. Crit Rev Oncol Hematol Bracarda S, Calabrò F, De Giorgi U, Procopio G, Sabbatini R, Porta C. PMID: 41423067 [PubMed - as supplied by publisher]
	Bacillus Calmette-GuÃ©rin-exposed Non-muscle-invasive Bladder Cancer: Survival Benchmarks, Bladder-sparing Strategies, and Implications for Trial Design. Eur Urol Focus Jazayeri SB, DiNatale RG, Guske C, Harrs C, Linscott J, Xu H, Davaro F, Wen L, Spiess PE, Sexton WJ, Gilbert SM, Zemp L, Poch MA, Li R. PMID: 41421932 [PubMed - as supplied by publisher]
	Re: Nikita Sushentsev, Anne Y. Warren, Richard Colling, et al. Active Monitoring, Surgery, and Radiotherapy for Cribriform-positive and Cribriform-negative Prostate Cancer: A Secondary Analysis of the PROTECT Randomized Clinical Trial. JAMA Oncol. In press. https://doi.org/10.1001/jamaoncol.2025.4125. Eur Urol Focus Bernardino R, Le Guevélou J, Autorino R, Gandaglia G, Marra G, Young Academic Urologists Prostate Group. PMID: 41421931 [PubMed - as supplied by publisher]
	Re: Final Overall Survival and Safety Analyses of the Phase III PSMAfore Trial of [(177)Lu]Lu-PSMA-617 Versus Change of Androgen Receptor Pathway Inhibitor in Taxane-Naive Patients with Metastatic Castration-Resistant Prostate Cancer. Eur Urol Barata PC, Grier AL. PMID: 41421925 [PubMed - as supplied by publisher]
	Local and locoregional prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Ann Oncol Walz J, Attard G, Bjartell A, Blanchard P, Castro E, Compérat E, Emmett L, Fanti S, Fonteyne V, Foulon S, Gillessen S, Gravis G, James ND, Oprea-Lager DE, Ost P, Padhani A, Parker C, Renard-Penna RM, Rubin MA, Saad F, Sweeney C, Tilki D, Tombal B, Tree AC, Zilli T, Fizazi K, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. PMID: 41421764 [PubMed - as supplied by publisher]
	Agent-Specific Differences in Sustained Intraoperative Hypotension during oral 5-Aminolevulinic Acid-Guided Transurethral Resection of Bladder Tumor: A Retrospective Observational Study. Photodiagnosis Photodyn Ther Katsumata Y, Yamamoto S, Iwata H, Kuroiwa H, Fukuhara H, Fukata S, Inoue K, Kawano T. PMID: 41421436 [PubMed - as supplied by publisher]
	Predictive value of quantitative parameters from dual-tracer FDG and PSMA PET/CT for progression to castration resistance in patients with metastatic hormone-sensitive prostate cancer. Eur J Radiol Xiang F, Zeng Y, Zhang Z, Zhang Y, Su W, Zhou M, Yu J, Luo C, Wu Y, Zheng F. PMID: 41421031 [PubMed - as supplied by publisher]
	Association of race and survival in patients treated with apalutamide: Pooled analysis of two phase 3 trials. Cancer Gebrael G, Agarwal N, Morgans AK, Vince R Jr, Swami U, Jia AY, Zaorsky N, Chehade CH, Ozay ZI, Malone S, Morgan SC, Wallis CJD, Kishan AU, Barata PC, Chowdhury S, Garcia JA, Sheng I, Brown JR, Small EJ, Sun Y, Shore ND, Saad F, Spratt DE, Roy S. PMID: 41420831 [PubMed - indexed for MEDLINE]
	Application of transurethral blue laser vaporization of the prostate in patients aged 80 and above: a single-center clinical analysis of 157 cases. Lasers Med Sci Wang C, Fu X, Ji Y, Cheng H, Wang S, Liu G, Fan Z, Qiao J, Xu X, Du Q. PMID: 41420775 [PubMed - indexed for MEDLINE]
	Retraction Note: Kidney cancer diagnosis and surgery selection by double Decker convolutional neural network from CT scans combined with great wall construction algorithm. Abdom Radiol (NY) Kumar H, Taluja A, Muniyandy E, Kolli S. PMID: 41420746 [PubMed - as supplied by publisher]
	Innovative AI model for bladder cancer diagnosis. Discov Oncol Jiang L, Ge W, Feng R, Ji L, Huo J, Li S, Fan T. PMID: 41420667 [PubMed - as supplied by publisher]
	Cellular Senescence in Kidney Diseases: From Bench to Clinic. FASEB J Shu S, Liu J, Yuan Q, Zhang C. PMID: 41420520 [PubMed - indexed for MEDLINE]
	Novel DNA methylation biomarkers in urine for non-invasive diagnosis of bladder urothelial carcinoma. Clin Epigenetics Shi C, Xu J, Chen Q, Gao X, Chen L, Jin C, Yu Z, Dou X. PMID: 41420251 [PubMed - indexed for MEDLINE]
	Discovery and validation of RAB3B as a diagnostic biomarker for prostate cancer with serum PSA below 10 ng/mL based on a multi-omics study. Cancer Cell Int Zhao C, Deng G, Chen J, Li H, Fan R, Fu Z, Ye D, Lai C, Di J. PMID: 41419883 [PubMed - as supplied by publisher]

Articles 1 - 20 / 184133

Page 1 of 9207



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy